CardieX Limited has announced that its subsidiary ATCOR was granted a new patent by the European Patent Office (EPO) for the company’s SphygmoCor technology used in cuff-based blood pressure devices.  

EPO Patent Number EP2566387 further protects the company’s intellectual property in relation to the measurement of a central blood pressure (BP) waveform with cardiovascular features using a brachial cuff. Patent EP2566387 specifically covers non-invasively estimating the heart’s pressure and pressure waveform related to cardiac function and arterial properties using a conventional BP cuff inflated to low pressure. The patent provides a simple tool to clinically diagnose and estimate the risk of heart disease. 

Examining officers from the EPO referenced the substantial differences to existing patents when granting the new patent to ATCOR, demonstrating the unique nature of the technology. The granting of the European patent follows similar patents granted in the United States and Japan with the new European patent in force until 2034.   

ATCOR currently sells the XCEL central blood pressure device and has a partnership with SunTech Medical for the Oscar 2 ABPM device, which both incorporate ATCOR’s SphygmoCor and brachial cuff technology. The company also recently announced a partnership with Andon for the development of a home-based BP device with advanced cardiovascular vital signs features.